This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Retinal/ Chorioretinal Disorders  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

Arch Ophthalmol. 2004;122:926-928.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Central serous chorioretinopathy (CSCR) is characterized by accumulation of fluid under the neurosensory retina and/or retinal pigment epithelium, resulting in a serous detachment that often involves the macula. Although the exact mechanism producing CSCR is unknown, increased adrenergic stimulation has been hypothesized to play a role.¹ Furthermore, elevated corticosteroid levels after systemic administration or secondary to endogenous sources have been implicated in the causation or exacerbation of CSCR.^2-3 Subtenon local corticosteroid injection is effective in the treatment of certain forms of uveitis. This report details a case of CSCR that developed after a single local subtenon corticosteroid injection to treat HLA-B27–associated iritis and was confirmed by optical coherence tomography (OCT).

Report of a Case

A healthy 37-year-old man was examined because of a 10-day history of progressive blurred vision, photophobia, and floaters in the left eye. Medical and social histories were noncontributory. The patient had had an upper respiratory tract infection 2 weeks before . . . [Full Text of this Article]

Comment
Caroline R. Baumal, MD, FRCSC; Adam Martidis, MD; Steven N. Truong, MD
Boston, Mass

Corresponding author: Caroline R. Baumal, MD. FRCSC, Department of Vitreoretinal Surgery, New England Eye Center, 750 Washington St, Box 450, Boston, MA 02111 (e-mail: cbaumal@tufts-nemc.org).